Please find the latest videos from entire, recent Evidence Life Science events.
Tessa Pugh
CEO
PharmaReview
Caroline Halford
Development Director for Medical Education
Springer Healthcare
David Braca
Regional Sales Director - US
Springer Healthcare
Samin Saeed
Chief Medical Officer
PharmaReview
Luke Rogers
Senior Director, Business Partnerships
Within3
Gemma Allen
Expert in Technology Innovation
Open Health
Oliver Childs
Expert in Creative Scientific Communications
Open Health
Chris Bassett
Sales Director
Springer Healthcare
Simon Fry
Digital Product Development Director
Springer Healthcare
Joaquin Casariego
Senior Advisor
Savana
Chris Rolfe
Consultant, Real-World Evidence
Open Health
Tessa Pugh
CEO
PharmaReview
Ignacio Medrano
Founder & Chief Medical Officer
Savana
The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices. Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.
Christina Hoffman
Global Head, Medscape Medical Affairs
Medscape Medical Affairs
Let's take the idea of KOL engagement a bit further! Discover how to bridge the knowledge gap in multiple communities by sharing scientific information with relevant stakeholders simultaneously thus leveraging existing networks, relationships, and channels to foster connections. Join us in exploring the ideas and hear a few practical real-life cases of community engagement.
Iola Forster
Strategic Competence Lead, Industry & Society Services
Karger Publishers
Geoff Covey
General Manager, Karger UK
Karger Publishers
Nina Levin
Vice President - Client Success
Within3
James Turnbull
Global Head of Omnichannel Communications
OPEN Health
Jenny Ghith
Senior Director, Omnichannel Strategy and Innovation Lead, Global Scientific Communications
Pfizer Oncology
Luke Rogers
Senior Director, Business Partnerships
Within3
Rosie Humphreys
Digital Communications Director
Open Health
Traditional methods of evidence generation from electronic health records are no longer fit for purpose. Discover how AI techniques such as clinical natural language processing (cNLP) can generate deep RWE to deliver clinical and economic value for industry. Hear about:
· The limitations of traditional methods of evidence generation from electronic health records
· The benefits of AI-based techniques such as cNLP
· A gold standard for high-quality RWE for deeper insights at scale and speed
· Ideas for applying deep RWE across the Pharma R&D and commercial lifecycle
Ignacio Medrano
Founder & Chief Medical Officer
Savana
Jessica Ingram
Senior Vice President, Learning & Development
OPEN Health Medical Communications
Sophie Officer-Thorley
Senior Account Manager - Learning and Development
OPEN Health Medical Communications
The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices. Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.
Christina Hoffman
Global Head, Medscape Medical Affairs
Medscape Medical Affairs
Innovation in an already crowded oncology space has created a challenge for medical affairs. The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the scientific need of experts, while continuously demonstrating value. To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to leverage this information to inform targeted decisions and investments.
Robert Groebel
Vice President - Global Medical Strategy
Monocl
Jeffrey Saffer
CEO and Co-founder
Quertle
Chahrazed Poignant
Business Development Manager
Karger
Gregor Bangert
Regional Manager
Karger
Tony Cox
Development Director Real-World Evidence
OPEN Health
Julya Zuenkova
Business Development Director
Xstrahl Group
COVID-19 significantly impacted how providers reach out to patients. Besides, there has been a series of changes in the reimbursement and funding of medical technologies and procedures. These aspects created opportunities to address new market needs and leverage data and learning to deliver more value to a growing network of payers, providers, and patients. Welcome to the new era of Network Value.
Ernesto M. Nogueira
CEO and Founder
ValueConnected
James Turnbull
Senior Vice President, Omnichannel & Digital
OPEN Health
Christina Hoffman
Global Head, Medscape Medical Affairs
Medscape Medical Affairs
Alessandro Pontes-Arruda
Vice-President, U.S. Medical Head Cardiovascular and Established Products
Sanofi
Gokhan Tanju
Executive Director, Business Intelligence
Medscape Medical Affairs
Eric Noehrenberg
President
NIPC
Luke Rogers
Senior Director, Business Partnerships
Within3
Innovation in an already crowded oncology space has created a challenge for medical affairs. The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the scientific need of experts, while continuously demonstrating value. To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to leverage this information to inform targeted decisions and investments.
Robert Groebel
Vice President - Global Medical Strategy
Monocl
Luke Rogers
Senior Director, Business Partnerships
Within3
Gemma Allen
Head of Digital Communications
Open Health
Luke Rogers
Senior Director, Business Partnerships
Within3
Joachim Flickinger
Head of Clinical & Patient Markets
Karger Publishers, Switzerland
Iola Gulijew
Strategic Competence Lead, Industry & Society Services
Karger Publishers, Switzerland
Within3 offers a virtual engagement platform that gives stakeholders the freedom to communicate anytime, anywhere, on any device
Luke Rogers
Senior Director, Business Partnerships
Within3
Helen Kane
Founder & Managing Director
ONE MSL, UK
Sergio Diaz
Patient-Centred Outcomes Consultant
OPEN VIE
Michael Weisser
CEO
AIM Gmbh (Assessment-in-Medicine)
The principles of market access differ greatly from traditional 4 P product price place promotion Marketing. The winning combination of clear demonstration of Patient, Provider Payer and Product benefits (Optimizing price but maximising the availability to patients who need the technology most) to HTA’s leads to faster adoption meaning patients receive great technologies sooner.
Michael Branagan-Harris
CEO
Device Access UK
Value Based Healthcare requires a new way of thinking. It requires fluently navigating clinical outcomes and economic costing. This presentation will cover WHY VBHC is necessary, HOW Value based procurement enables VBHC, WHO needs to be involved in the collaborative dialogue, and WHAT the role of VBAPs are in overcoming clinical and economic uncertainty to drive medtech adoption.
Ernesto M. Nogueira
CEO and Founder
ValueConnected
Nicolai Nygaard Worsøe
Client Director
Agnitio
Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK
Pauline De Mari
Vaccines Innovative Medical Engagement Lead
Sanofi
Andy Bowman
Managing Director
Within3
Amy Pinelli
Regional Vice President, Business Partnerships
Within3
As the life sciences industry shifts its understanding of customers to help meet organizational goals, account management can help power strategic partnerships in an increasingly complex healthcare landscape. The session audience will learn:
Robert Groebel
Vice President - Global Medical/KAM Strategy
Veeva Systems
Thomas Fast
Project Manager & RWE Expert
Institute of Applied Economics & Health Research (ApHER)
Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands
Industry consolidation, competition and product innovation are driving the medical device industry to constantly evolve if they are to keep up with market and patient needs. This poses a great challenge, but also a great opportunity, to learning and enablement leaders who strive to successfully support sales, medical affairs and distribution partners to develop strong customer relationships and deliver the best technology solutions for the end patient or consumer. In this talk, you will learn:
Michael Connolly
Enterprise Account Director, EMEA
Qstream, UK
Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK
Charlotte Moseley
Global Head
Complete HealthVizion, UK
Gavin Kenny
Account Director
OPEN Health Medical Communications, UK
The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.
Mark Steedman
Research Manager
Deloitte UK Centre for Health Solutions
Richard Daly
CEO
DNAnexus, Inc., USA
Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting
Richard Macaulay
Principal Consultant
Parexel
Akshay Kumar
Principal Consultant
Huron Consulting Group, UK
Ernesto M. Nogueira
Managing Director
ValueConnected
Ben Modley
Director of European Operations
ValueConnected
Amanda Pulfer
Managing Director
PH Associates
Torkild Stenbock
General Manager
LINK Medical Research, Norway
Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands
Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands
Ellen Atkinson
Account Executive
Showpad
Anthony Page
CEO
Voxx Analytics
Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.
Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape
Ernesto M. Nogueira
Managing Director
ValueConnected
Ernesto M. Nogueira
Managing Director
ValueConnected
Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK
Kieron Lewis
Global Business Development Director
Clinigen, UK
Annie Rankin
Client Partnerships Lead
Succinct Medical Communications
Gavin Kenny
Account Director
Succinct Medical Communications
Katie Corbin
Managing Director
Succinct Medical Communications
Richard Jones
Patient Services Director
The Earthworks (an OPEN Health Company)
- Real world data solutions in the post-marketing world: the multiple sclerosis experience
- Introduction to the MSBase international registry
- Methods for separating drug signals from bias in observational data
- Pharma / disease registry collaborations in comparative effectiveness analyses
- Big data: Big MS and beyond
Tim Spelman
Senior Scientist
Synergus
Shane West
VP Client Relations
Cetas Healthcare Insights, Norway
Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, India
Anne Smart
Managing Director
ClearView Healthcare Partners, USA
Nourdine Bouzekri
Principal Industry Consultant
SAS, France
Peter Grolimund
Sr. Life Science Industry Consultant
ThinkBig Analytics (a Teradata company)
Ernesto M. Nogueira
Managing Director
Value Connected, Netherlands
Mattias Kyhlstedt
CEO
Synergus AB, Denmark
Ernesto M. Nogueira
Managing Director
ValueConnected
Rob Wenthold
Vice President
Boston Healthcare Associates
William C Maier
Chief Scientific Officer and Head of Patient-Centered Sciences
Mapi Group
Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK
Rhiannon Meaden
Head of Commercial Development
Complete HealthVizion, UK
Chris Easley
Head of Market Access Solutions
Pope Woodhead and Associates Ltd.
Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA
Tim Day
Principal
Innovative Strategic Communications
With the rise of medical affairs as healthcare’s core scientific partner, industry leaders are reimagining their organizations to achieve a world-class standard–and deliver greater value. Learn how to align engagement strategies to healthcare stakeholders’ scientific goals and interests, based on actionable insights.
Robert Groebel
Vice President - Global Medical Strategy
Veeva
Brian Harper
Senior Director, Medical Content Strategy
Veeva
Adrien Gras
Vice President Europe, Market Access
GFK, UK
Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA
Sumit Mehta
Managing Director
Cetas Healthcare Insights
Jay Bratcher
Training Manager, New Cardio, Europe
Boston Scientific, UK
Michael Quann
Director Strategic Account
Qstream, Ireland
Sital Kotecha
Medical Strategy Director, Europe
Veeva Systems, UK
Tim Day
CEO & Principal
Innovative Strategic Communications, USA
Mark Wolff
Advisory Industry Consultant, Chief Health Analytics Strategist
Health & Life Sciences Global Practice, SAS Institute, USA
Alexander Frenzel
Senior Manager, Business Development T&A, QuintilesIMS, Germany
Charles Mathews
Vice President
Boston Healthcare, USA
Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands
Tiberio Catania
Commercial Director
EPG Health Media, UK
A plethora of studies suggest that an astonishing 50 – 75% of all CRM implementations fail in some form. So we started our KOL CRM development programme with the assumption “why should ours be any different?” Our two-year case study highlights the many challenges we (vendor & our clients) encountered in the medical affairs context, our many failings, and the innovations we built to overcome them. We’ll also present a simple framework for Medical Affairs to help maximise the success of CRM implementations to boost external expert management.
Sanjay Singhvi
Director, System Analytic, UK
Mason W. Russell
MAPE, Vice President
Truven Health Analytics, USA
Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.
Miguel Martin de Bustamante
Associate, CBPartners
Sandeep Duttagupta
Vice President, CBPartners
Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services,
PRA Health Sciences
William Maier
Chief Scientific Officer, Mapi Group, UK
Isabelle Grau
Director, Real World Evidence APAC, Mapi Group, Australia
Gustav Ando
Vice President of Life Sciences
IHS
Anke van Engen
Principal, Advisory Services, Quintiles, Netherlands
Ian Smyth
Director
MEDNET Consult
Rob Barker
CEO, Succinct Medical Communications, UK
The MedTech industry is at an inflection point. Healthcare providers at every level are professionalising their procurement and creating tectonic shifts in their demands on your pricing, sales, and tendering and contracting operations. While the industry appears to be aware of these shifts and what the impacts will be, many MedTech companies are struggling to identify and prioritise the changes they need to make to stay ahead of these trends without sacrificing revenue or growth.
Peter Zimmermann
Director Customer Success Europe
Model N, Switzerland
Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands
Life sciences organisations need to dramatically reduce analytics time and speed up clinical interventions, but most still rely on shipping physical disks due to inherent problems with existing networks and transfer protocol inefficiencies. Spending days to transport data is not a viable option, this session will explore technology infrastructure for file transfer that will catalyse the transition from 1GbE to 10GbE and beyond.
Per Hansen
Regional Manager Sales Engineering EMEA, Aspera (an IBM Company),UK
Thomas Wilckens
Chief Executive Officer, CSO & Founder, InnVentis, Germany
Stuart Mealing
Principal Economist, European Practice Lead
ICON, UK
Ernesto M. Nogueira
Managing Director
ValueConnected, Netherlands
Joanna Entwistle
Principal Consultant, GFK Market Access, UK
How do we avoid the greatest threat to carefully crafted medical strategy – the inevitable boiling down of delicately nuanced arguments into bullet points, charts and tables? To the outside observer it appears to be largely generic and is hardly reassuring to senior stakeholders who must bless it, or clear to those who must ultimately implement it. This presentation will discuss how to create and communicate your medical strategy in a way that informs and inspires the reader.
Robert Barker
CEO, Succinct Medical Communications, UK
W. Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.
Norbert Wilk
Director, Market Access Consulting
Arcana Institute, Poland
Karen Wai
Vice President, Regional Managing Director Real-World & Late Phase Research, Asia Pacific
Quintiles, Singapore
Sheryl Jacobson
Asia Head of Life Science and Healthcare Consulting
Deloitte
Myriam El-Khazen
General Manager
INC Research, Greece
Istvan Udvaros
Medical Director, Project Director of Oncology
SGS LSS Clinical Research, Belgium
Agnes Rethy
Associate Director of Clinical Operations
EDS Patient Pharmacology Services
PRA Health Services
Anne Smart
Director
Navigant, USA
Gillian Boucher
Director, Medical Writing and Editorial
Quintiles
Sanjay Singhvi
Director
System Analytic, UK
Louella Morton
VP International Sales & General Manager
Qstream
In today’s digital age, marketers can use marketing automation and analytics technology enabling them to be hyper-relevant to the customer via online channels. But what happens when the customer schedules a call or meeting with your sales team? How do you know whether or not your content performs well during this offline phase of the customer journey? Learn how to grow your business by supporting your sales and indirect channels with sales driven marketing.
Pieterjan Bouten
Chief Executive Officer
Showpad, Belgium
Geoff Cable
CEO & co-Founder
NextLevel Life Sciences
Luke Rogers
CEO & co-Founder
NextLevel Life Sciences